TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

J&J Stock Sinks as Feds Probe Baby Powder Cancer Allegations
MERGERS AND ACQUISITIONS

Johnson & Johnson Shuts Insulin Pump Business, Inks Other Deals

Alcobra Shares Plummet as ADHD Drug Fails
STOCKS

Alcobra shares plummet as ADHD drug fails

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive
STOCKS

Corbus Pharma bear thesis is alive and well

FDA deals blow to Endo over Opana ER Pain Med
MARKETS

Alcobra (ADHD) Stock Sliding, Downgraded After FDA Clinical Hold

ON Semiconductor (ON) Stock Falls on Disappointing Q1 Revenue
MARKETS

Alcobra (adhd) stock tumbles on fda clinical hold, cantor remains bullish

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
OPINION

7 stocks under $10 making big moves higher

Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
STOCKS

Alcobra Placebo Beats Drug in Failed Genetic Disease Study

5 Stocks Poised for Big Breakouts: Xoom, Alcobra and More
INVESTING

5 Stocks Poised for Big Breakouts: Xoom, Alcobra and More

5 Stocks Under $10 to Trade for Breakouts: SouFun, Repros and More
INVESTING

5 Stocks Under $10 to Trade for Breakouts: SouFun, Repros and More

Germany's Merck Lifts Full-Year Guidance After Sigma-Aldrich Boosts Sales
INVESTING

4 Biotech Stocks Under $10 to Trade for Breakouts: Sophiris, Atossa and More

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Alcobra Applies Revisionist History to ADHD Drug Study Analysis

5 Stocks Under $10 Set to Soar
INVESTING

5 Stocks Under $10 Set to Soar

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
INVESTING

It's True, Small-Cap Biotech Stocks Are Acting Badly These Days

HCA Holdings (HCA) Stock Gains After Supreme Court Ruling
MARKETS

Why Alcobra (ADHD) Stock Hit a One-Year Low Today

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Alcobra ADHD Drug Fails Key Study Except When Patients Removed From Analysis

CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

Why Alcobra Investors Are So Nervous About a Coming Drug Study

Pan American Silver (PAAS) Stock Gains on Heavy Trading Volume
MARKETS

Why Alcobra (ADHD) Stock Is Declining Today

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Your September Biotech Back-to-School Calendar

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014

4 Huge Stocks on Traders' Radars
INVESTING

3 Big-Volume Stocks to Trade for Breakouts

3 Unusual-Volue Stocks on the Rise
INVESTING

5 Stocks Spiking on Unusual Volume

5 Stocks Ready to Break Out
INVESTING

5 Stocks Ready to Break Out

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Biotech Stock Bubble Debate in 14 Charts

Alcobra Plans to Break ADHD Ranks
VIDEO

Alcobra Plans to Break ADHD Ranks